Alnylam Pharmaceuticals (ALNY) Selling, General & Administrative (2009 - 2026)
Alnylam Pharmaceuticals (ALNY) Selling, General & Administrative (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -10.08 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 2.17 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 555.10 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 493.70 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 647.70 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 17.02 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -355.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 101.25 Mn |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | 322.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 322.55 Mn |
| Dec 31, 2025 | 325.37 Mn |
| Sep 30, 2025 | 322.08 Mn |
| Jun 30, 2025 | 323.31 Mn |
| Mar 31, 2025 | 239.95 Mn |
| Dec 31, 2024 | 295.34 Mn |
| Sep 30, 2024 | 220.99 Mn |
| Jun 30, 2024 | 248.40 Mn |
| Mar 31, 2024 | 210.80 Mn |
| Dec 31, 2023 | 198.12 Mn |
| Sep 30, 2023 | 199.18 Mn |
| Jun 30, 2023 | 214.69 Mn |
| Mar 31, 2023 | 183.66 Mn |
| Dec 31, 2022 | 210.34 Mn |
| Sep 30, 2022 | 235.86 Mn |
| Jun 30, 2022 | 169.98 Mn |
| Mar 31, 2022 | 154.47 Mn |
| Dec 31, 2021 | 186.38 Mn |
| Sep 30, 2021 | 142.08 Mn |
| Jun 30, 2021 | 145.32 Mn |